(Q44123961)

English

Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

stem cell transplantation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Mollee P

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Pereira D

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Nagy T

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Song K

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Saragosa R

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Keating A

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Crump M

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

273-278

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703653

0 references

Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate dose cyclophosphamide and G-CSF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

21 January 2018

Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphom

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

21 January 2018

A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

21 January 2018

A comparison of peripheral blood stem cell mobilisation after chemotherapy with cyclophosphamide as a single agent in doses of 4 g/m2 or 7 g/m2 in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

21 January 2018

ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

21 January 2018

Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

21 January 2018

Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

21 January 2018

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of patients with malignant lymphoma with Mini-BEAM reduces the yield of CD34+ peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

Previous treatment predicts the efficiency of blood progenitor cell mobilisation: validation of a chemotherapy scoring system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte-colony-stimulating factor: an analysis of 497 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of two doses of cyclophosphamide with etoposide and G-CSF for mobilization of peripheral blood stem cells in 318 patients with stage II-III breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703653

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703653

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44123961&oldid=2106829855"